Patents by Inventor John P.A. Grimshaw

John P.A. Grimshaw has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Protein sustained-release injectable formulation
    Patent number: 10093726
    Abstract: The present invention provides sustained-release pharmaceutical formulations for administering proteins to the eye. In particular, the invention provides formulations comprising single chain antibodies and hydrophobic polyester hexylsubstituted poly(lactic acid) (hexPLA). The invention further provides processes for the production of sustained-release pharmaceutical formulations and medical uses thereof.
    Type: Grant
    Filed: August 24, 2016
    Date of Patent: October 9, 2018
    Assignee: ESBATech, an Alcon Biomedical Research Unit LLC
    Inventors: Lutz Asmus, Michael Möller, Robert Gurny, John P. A. Grimshaw
  • Protein sustained-release injectable formulation
    Patent number: 9873736
    Abstract: The present invention provides sustained-release pharmaceutical formulations for administering proteins to the eye. In particular, the invention provides formulations comprising single chain antibodies and hydrophobic polyester hexylsubstituted poly(lactic acid) (hexPLA). The invention further provides processes for the production of sustained-release pharmaceutical formulations and medical uses thereof.
    Type: Grant
    Filed: August 18, 2014
    Date of Patent: January 23, 2018
    Assignee: ESBATech, an Alcon Biomedical Research Unit LLC
    Inventors: Lutz Asmus, Michael Möller, Robert Gurny, John P. A. Grimshaw
  • PROTEIN SUSTAINED-RELEASE INJECTABLE FORMULATION
    Publication number: 20150044213
    Abstract: The present invention provides sustained-release pharmaceutical formulations for administering proteins to the eye. In particular, the invention provides formulations comprising single chain antibodies and hydrophobic polyester hexylsubstituted poly(lactic acid) (hexPLA). The invention further provides processes for the production of sustained-release pharmaceutical formulations and medical uses thereof.
    Type: Application
    Filed: August 18, 2014
    Publication date: February 12, 2015
    Inventors: Lutz Asmus, Michael Möller, Robert Gurny, John P.A. Grimshaw